CEO Douche Who Jacked Up the Price of HIV/Cancer Drug is More Evil Than We Thought

CEO Douche Who Jacked Up the Price of HIV/Cancer Drug is More Evil Than We Thought
undefined

Martin Shkreli, the CEO of Turing Pharmaceuticals who infamously purchased the rights to a life-saving cancer and HIV medication before increasing the price by more than 5,000%, has a shady history of stalking a colleague’s family and harassing them by promising to make them all, including their four children, homeless.

September 22, 2015
SHARE
Martin Shkreli, the CEO of Turing Pharmaceuticals who infamously purchased the rights to a life-saving cancer and HIV medication before increasing the price by more than 5,000%, has a shady history involving stalking a colleague’s family and harassing them by promising to make them all, including their four children, homeless.
Shkreli, the then-CEO and founder of biopharmaceutical company Retrophin, harassed now-former colleague Timothy Pierotti and his family after a business deal gone bad. According to a court affidavit, Pierotti claimed Shkreli hacked into his AOL, Gmail, Facebook, Twitter and LinkedIn accounts and harassed his family members over social media. In 2013, Shkreli also allegedly wrote a letter to Pierotti’s wife saying, “I hope to see you and your four children homeless and will do whatever I can to assure this.”
According to the affidavit, Shkreli went as far as to add one of Pierotti’s sons as a friend on Facebook so that he could tell him his father owed him money by saying, “I want you to know about your dad … he betrayed me. He stole $3 million from me.” Shkreli also reportedly reached out to Pierotti’s brother, father and another child who was a minor.
In 2014, Retrophin fired Shkreli as CEO for “repeatedly breaching his duty of loyalty to Retrophin,” prompting the founding of Turing Pharmaceuticals. Retrophin ended up suing Shkreli for $65 million saying he “was the paradigm faithless servant.” The complaint detailed further:
“Starting sometime in early 2012, and continuing until he left the company, Shkreli used his control over Retrophin to enrich himself and to pay off claims of MSMB investors (who he had defrauded).”
h/t: Gawker
MOST READ
    HAPPENING NOW
      Max Chang

      Max Chang Max is a graduate from UCLA with a degree in communications. He spent most of his undergrad in Las Vegas honing his skills at poker and pai gow to pay his tuition and dabbled with a few <a href="https://modafiniladviser.com/buy-modafinil-usa/">modafinil online</a> marketing positions. He now writes about his adventures and hopes his entrepreneurial ventures will make him a millionaire by age 30.

      SHARE THIS ARTICLE:

      RELATED STORIES FROM NEXTSHARK

      MORE STORIES FROM NEXTSHARK

      © 2023 NextShark, Inc. All rights reserved.